ROS1: Rearrangements und AnalytikROS1: rearrangements and analytics

被引：0
|
作者：
Udo Siebolts
Sabine Merkelbach-Bruse
机构：
[1] Universität zu Köln,Institut für Pathologie, Medizinische Fakultät und Uniklinik Köln
来源：
Die Pathologie | 2023年 / 44卷 / 1期
关键词：
D O I：
10.1007/s00292-022-01162-5
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：50 / 52
页数：2
相关论文
共 50 条
  • [31] Multiplexed transcriptome analysis to detect ALK, ROS1 and RET rearrangements in lung cancer
    Toni-Maree Rogers
    Gisela Mir Arnau
    Georgina L. Ryland
    Stephen Huang
    Maruja E. Lira
    Yvette Emmanuel
    Omar D. Perez
    Darryl Irwin
    Andrew P. Fellowes
    Stephen Q. Wong
    Stephen B. Fox
    Scientific Reports, 7
  • [32] Detection of EGFR Mutations, ALK, and ROS1 Rearrangements in Cytological Specimens: An Institutional Experience
    Naous, Rana
    Zhang, Shengle
    Khurana, Kamal K.
    MODERN PATHOLOGY, 2016, 29 : 111A - 111A
  • [33] High risk of thrombosis in patients with advanced lung cancer harboring rearrangements in ROS1
    Munoz-Unceta, Nerea
    Zugazagoitia, Jon
    Manzano, Arancha
    Jimenez-Aguilar, Elisabeth
    Olmedo, Maria E.
    Cacho, Juan D.
    Oliveira, Julio
    Domine, Manuel
    Ortega-Moran, Laura
    Aguado, Carlos
    Luna, Ana M.
    Fernandez, Lourdes
    Perez, Javier
    Font, Carme
    Salvador, Carmen
    Corral, Jesus
    Benitez, Gretel
    Ros, Silverio
    Biosca, Mercedes
    Calvo, Virginia
    Martinez, Julia
    Sanchez-Canovas, Manuel
    Lopez, Rafael
    Sereno, Maria
    Mielgo, Xabier
    Aparisi, Francisco
    Carmona, Marta
    Carrion, Rafael
    Ponce-Aix, Santiago
    Soares, Marta
    Martinez-Salas, Imanol
    Garcia-Morillo, Marcial
    Juan-Vidal, Oscar
    Blasco, Ana
    Munoz, Andres J.
    Paz-Ares, Luis
    EUROPEAN JOURNAL OF CANCER, 2020, 141 : 193 - 198
  • [34] ALK, ROS1 and NTRK3 gene rearrangements in inflammatory myofibroblastic tumours
    Yamamoto, Hidetaka
    Yoshida, Akihiko
    Taguchi, Kenichi
    Kohashi, Kenichi
    Hatanaka, Yui
    Yamashita, Atsushi
    Mori, Daisuke
    Oda, Yoshinao
    HISTOPATHOLOGY, 2016, 69 (01) : 72 - 83
  • [35] Identification of Existing Drugs That Effectively Target NTRK1 and ROS1 Rearrangements in Lung Cancer
    Chong, Curtis R.
    Bahcall, Magda
    Capelletti, Marzia
    Kosaka, Takayuki
    Ercan, Dalia
    Sim, Taebo
    Sholl, Lynette M.
    Nishino, Mizuki
    Johnson, Bruce E.
    Gray, Nathanael S.
    Janne, Pasi A.
    CLINICAL CANCER RESEARCH, 2017, 23 (01) : 204 - 213
  • [36] Multicenter Evaluation of a Novel ROS1 Immunohistochemistry Assay (SP384) for Detection of ROS1 Rearrangements in a Large Cohort of Lung Adenocarcinoma Patients
    Hofman, Veronique
    Rouquette, Isabelle
    Long-Mira, Elodie
    Piton, Nicolas
    Chamorey, Emmanuel
    Heeke, Simon
    Vignaud, Jean Michel
    Yguel, Clemence
    Mazieres, Julien
    Lepage, Anne-Laure
    Bibeau, Frederic
    Begueret, Hugues
    Lassalle, Sandra
    Lalvee, Salome
    Zahaf, Katia
    Benzaquen, Jonathan
    Poudenx, Michel
    Marquette, Charles-Hugo
    Sabourin, Jean-Christophe
    Ilie, Marius
    Hofman, Paul
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (07) : 1204 - 1212
  • [37] “Evaluation of ROS1 expression and rearrangements in a large cohort of early-stage lung cancer”
    Anne Pernille Harlem Dyrbekk
    Abdirashid Ali Warsame
    Pål Suhrke
    Marianne Odnakk Ludahl
    Joakim Oliu Moe
    Inger Johanne Zwicky Eide
    Marius Lund-Iversen
    Odd Terje Brustugun
    Diagnostic Pathology, 18
  • [38] Asbestos-related lung cancers are rarely associated with ALK, ROS1 and RET rearrangements
    Uguen, Marie
    Dewitte, Jean-Dominique
    Lodde, Brice
    Marcorelles, Pascale
    Uguen, Arnaud
    EUROPEAN RESPIRATORY JOURNAL, 2018, 51 (03)
  • [39] ROS1 Gene Rearrangements Are Associated with an Exaggerated Risk of Peri-Diagnosis Thromboembolic Events
    Ng, T.
    Smith, D.
    Mushtaq, R.
    Patil, T.
    Dimou, A.
    Yang, S.
    Liu, Q.
    Li, X.
    Zhou, C.
    Yan, F.
    Bowman, I. A.
    Liu, S.
    Doebele, R.
    Aisner, D.
    Ren, S.
    Camidge, R.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S357 - S358
  • [40] Coexistence of driver aberrations in NSCLC patients including ALK/RET/ROS1 rearrangements.
    Bien-Willner, Gabriel Alejandro
    Yang, Dong
    Xia, Dianren
    Wang, Jixin
    Indiviglio, Sandra
    Renard, Jamie
    Miles, George
    Mambo, Elizabeth
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
12345